Hsbc Holdings PLC trimmed its stake in shares of Maximus, Inc. (NYSE:MMS – Free Report) by 68.7% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 4,351 shares of the health services provider’s stock after selling 9,535 shares during the period. Hsbc Holdings PLC’s holdings in Maximus were worth $279,000 as of its most recent SEC filing.
Other institutional investors have also added to or reduced their stakes in the company. Norges Bank bought a new position in Maximus during the 4th quarter worth about $60,393,000. River Road Asset Management LLC boosted its position in shares of Maximus by 236.1% during the fourth quarter. River Road Asset Management LLC now owns 823,262 shares of the health services provider’s stock worth $71,064,000 after buying an additional 578,326 shares during the period. Goldman Sachs Group Inc. grew its holdings in shares of Maximus by 218.4% during the fourth quarter. Goldman Sachs Group Inc. now owns 583,627 shares of the health services provider’s stock worth $50,379,000 after buying an additional 400,315 shares in the last quarter. Boston Partners raised its position in Maximus by 47.0% in the 3rd quarter. Boston Partners now owns 966,139 shares of the health services provider’s stock valued at $88,236,000 after buying an additional 308,892 shares during the last quarter. Finally, The Manufacturers Life Insurance Company lifted its stake in Maximus by 493.0% in the 4th quarter. The Manufacturers Life Insurance Company now owns 342,266 shares of the health services provider’s stock valued at $29,544,000 after acquiring an additional 284,548 shares in the last quarter. 97.21% of the stock is owned by institutional investors.
Analyst Ratings Changes
MMS has been the subject of several research reports. Wall Street Zen raised shares of Maximus from a “hold” rating to a “buy” rating in a research note on Saturday, June 6th. Zacks Research cut shares of Maximus from a “strong-buy” rating to a “hold” rating in a report on Monday, April 27th. Finally, Weiss Ratings downgraded shares of Maximus from a “hold (c)” rating to a “hold (c-)” rating in a research report on Wednesday, May 20th. Two equities research analysts have rated the stock with a Hold rating, According to MarketBeat.com, Maximus presently has a consensus rating of “Hold”.
Maximus Price Performance
NYSE:MMS opened at $60.27 on Monday. Maximus, Inc. has a 12-month low of $52.73 and a 12-month high of $100.00. The firm has a market capitalization of $3.17 billion, a price-to-earnings ratio of 9.02 and a beta of 0.59. The stock’s 50 day moving average price is $58.68 and its two-hundred day moving average price is $68.52. The company has a quick ratio of 2.21, a current ratio of 2.21 and a debt-to-equity ratio of 0.87.
Maximus (NYSE:MMS – Get Free Report) last issued its earnings results on Thursday, May 7th. The health services provider reported $2.07 EPS for the quarter, topping the consensus estimate of $1.98 by $0.09. The company had revenue of $1.31 billion during the quarter, compared to the consensus estimate of $1.32 billion. Maximus had a return on equity of 25.10% and a net margin of 7.02%.The firm’s revenue for the quarter was down 4.1% compared to the same quarter last year. During the same period in the previous year, the company posted $2.01 EPS. Maximus has set its FY 2026 guidance at 8.250-8.550 EPS. On average, analysts anticipate that Maximus, Inc. will post 8.43 earnings per share for the current year.
Maximus Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Monday, August 31st. Shareholders of record on Friday, August 14th will be given a dividend of $0.33 per share. This represents a $1.32 dividend on an annualized basis and a yield of 2.2%. The ex-dividend date of this dividend is Friday, August 14th. Maximus’s payout ratio is 19.76%.
Maximus Profile
Maximus, Inc (NYSE: MMS) is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children’s Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.
See Also
- Five stocks we like better than Maximus
- 3 Fixed-Income ETFs Show Why Yield Is Only Part of the Income Story
- AbbVie Quietly Solved Its Biggest Problem—Now What?
- Rio Tinto’s Results Make the Case for Looking Beyond Tech in the AI Trade
- Strategy’s Structural Strength: Hidden in a $8 Billion Illusion
Receive News & Ratings for Maximus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus and related companies with MarketBeat.com's FREE daily email newsletter.
